Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal haemodynamics during contrast media application in high-risk cardiac catheterisation patients
2004-005172-17Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic kidney disease (CKD) comparing Visipaque 320 arm, Omnipaque 300 arm and Ultravist 300 arm (3 arms). Primary endpoint: Integral of renal flow velocity after contrast media application. Started May 2006; status: completed.
02
Drugs
iodixanoliohexoliopromide
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2004-005172-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005172-17.